User:Mr. Ibrahem/Tenofovir alafenamide

Tenofovir alafenamide, sold under the brand name Vemlidy, is a medication for the treatment of chronic hepatitis B in those with compensated liver disease. It is taken by mouth. It can be used in people over the age of 11. Hepatitis B may worsen after stopping the medication.

Common side effects include headache, nausea, and tiredness. Other side effects may include lactic acidosis. It is not recommended in severe liver problems. Tenofovir alafenamide is converted by the body to tenofovir, by which it works. This than blocks reverse transcriptase which prevents the virus from multiplying.

Tenofovir alafenamide was approved for use in the United States in 2016 and Europe in 2017. In the United States it costs about US$1,300 per month as of 2021. In the United Kingdom this amount costs the NHS about £325 and in Canada it is about 600 CAD.